City State Bank’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Hold
850
﹤0.01% 498
2026
Q1
$7.74K Hold
850
﹤0.01% 568
2025
Q4
$11.6K Hold
850
﹤0.01% 520
2025
Q3
$18.5K Hold
850
0.01% 456
2025
Q2
$10.1K Hold
850
﹤0.01% 512
2025
Q1
$10.1K Hold
850
﹤0.01% 507
2024
Q4
$13.1K Hold
850
﹤0.01% 475
2024
Q3
$9.53K Hold
850
﹤0.01% 502
2024
Q2
$4.58K Hold
850
﹤0.01% 568
2024
Q1
$6K Hold
850
﹤0.01% 543
2023
Q4
$6K Hold
850
﹤0.01% 524
2023
Q3
$4K Hold
850
﹤0.01% 567
2023
Q2
$6K Buy
850
+350
+70% +$2.98K ﹤0.01% 541
2023
Q1
$4K Hold
500
﹤0.01% 571
2022
Q4
$4K Hold
500
﹤0.01% 546
2022
Q3
$5K Hold
500
﹤0.01% 518
2022
Q2
$7K Hold
500
﹤0.01% 487
2022
Q1
$5K Buy
500
+275
+122% +$2.5K ﹤0.01% 550
2021
Q4
$3K Buy
+225
New +$3.37K ﹤0.01% 581

Other funds holding CLPT

City State Bank's CLPT Position: Q2 2026 in Review

City State Bank held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 850 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

City State Bank first reported a position in CLPT in Q4 2021 and has held it in 19 quarters since. The position peaked at $18.5K in Q3 2025. 25 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • City State Bank held 850 shares of ClearPoint Neuro worth $15.2K as of Q2 2026.
  • City State Bank left its ClearPoint Neuro share count unchanged in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #498 holding.
  • City State Bank first reported a position in ClearPoint Neuro in Q4 2021 and has held it in 19 quarters since.
  • City State Bank's ClearPoint Neuro position peaked at $18.5K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.